MedMira Valuation

Is MIR undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MIR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MIR's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MIR's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MIR?

Key metric: As MIR barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for MIR. This is calculated by dividing MIR's market cap by their current book value.
What is MIR's PB Ratio?
PB Ratio	-3.2x
Book	-CA$16.86m
Market Cap	CA$54.06m

MIR key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	172.1x
Enterprise Value/EBITDA	-31.1x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does MIR's PB Ratio compare to its peers?

The above table shows the PB ratio for MIR vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	13.5x
TLT Theralase Technologies	44.1x	71.9%	CA$73.1m
ASG Aurora Spine	4.9x	n/a	CA$34.5m
NSCI Nanalysis Scientific	1.8x	n/a	CA$41.3m
PINK Perimeter Medical Imaging AI	3.1x	-12.3%	CA$56.0m
MIR MedMira	n/a	n/a	CA$54.1m

Price-To-Book vs Peers: MIR has negative equity and a Price-To-Book Ratio (-3.2x) compared to the peer average (13.5x).

Price to Book Ratio vs Industry

How does MIR's PB Ratio compare vs other companies in the CA Medical Equipment Industry?

2 Companies	Price / Book	Estimated Growth	Market Cap
SCYB Scryb	0.4x	n/a	US$3.44m
ASEP ASEP Medical Holdings	0.3x	n/a	US$2.75m

No more companies available in this PB range

2 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: MIR has negative equity and a Price-To-Book Ratio (-3.2x) compared to the North American Medical Equipment industry average (2.5x).

Price to Book Ratio vs Fair Ratio

What is MIR's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MIR PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	-3.2x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate MIR's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

NeuPath Health

CA$9.6m

Provides chronic pain management services in Canada.

NPTH

CA$0.16

-5.9%

Hamilton Thorne

CA$344.7m

Develops, manufactures, and sells precision instruments, laboratory equipment, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets.

HTL

CA$2.24

79.2%

Medical Facilities

CA$362.7m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

CA$15.87

83.9%